Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca lung and breast cancer data at WCLC and ESMO 2021 underscore ambition to revolutionise outcomes for patients
-
Forxiga approved in Japan for the treatment of chronic kidney disease in patients with and without type-2 diabetes
-
ALXN1840 FoCus Phase III trial in Wilson disease met primary endpoint demonstrating improvement in copper mobilisation from tissues
-
Update on CHAMPION-ALS Phase III trial of Ultomiris in amyotrophic lateral sclerosis
-
AZD7442 PROVENT Phase III prophylaxis trial met primary endpoint in preventing COVID-19
-
Update on US regulatory review of roxadustat in anaemia of chronic kidney disease
-
Forxiga approved in the EU for the treatment of chronic kidney disease in patients with and without type-2 diabetes
-
Enhertu significantly improved progression-free survival in DESTINY-Breast03 head-to-head trial vs. trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer
-
Saphnelo (anifrolumab) approved in the US for moderate to severe systemic lupus erythematosus
-
H1 2021 results
Latest articles and press releases
All of our latest press releases and articles are available to explore
